Be a Smart Investor
Tuesday, November 15, 2016
Dynavax Technologies Corp. (DVAX) Tumbled To A New Low After FDA Letter
Dynavax Technologies Corp. (DVAX) announced Monday morning that it has received a Complete Response Letter from the FDA regarding HEPLISAV-B.
from RTT - Before the Bell http://ift.tt/2ftO7lx
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment